Neuroscience and Behavioral Physiology

, Volume 24, Issue 6, pp 485–488 | Cite as

Features of the parkinsonian syndrome induced experimentally by a deficit of nigrostriatal dopamine and stimulation of cholinergic neurons of the caudate nuclei

  • G. N. Kryzhanovskii
  • M. A. Atadzhanov
  • T. A. Voronina
  • L. N. Nerobkova
Article
  • 13 Downloads

Keywords

Dopamine Caudate Nucleus Cholinergic Neuron Parkinsonian Syndrome Nigrostriatal Dopamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    M. N. Aliev, S. I. Igon'kina, and G. N. Kryzhanovskii, M. A. Atadzhanov,Byull. Éksp. Biol., No. 12, 657–659 (1981).Google Scholar
  2. 2.
    A. M. Vein, V. L. Golubev, and Yu. É. Verzyn'sh,Parkinsonism: Clinical Picture, Etiology, Pathogenesis, and Treatment [in Russian], Riga (1981).Google Scholar
  3. 3.
    O. V. Godukhin,The Modulation of Synaptic Transmission in the Brain [in Russian], Moscow (1987).Google Scholar
  4. 4.
    E. I. Kandel,Functional and Stereotaxic Surgery [Russian translation], Moscow (1981).Google Scholar
  5. 5.
    G. N. Kryzhanovskii,Determinant Structures in Nervous System Pathology [in Russian], Moscow (1980).Google Scholar
  6. 6.
    G. N. Kryzhanovskii, M. A. Atadzhanov, S. V. Magaeva, et al.,Byull. Éksp. Biol., No. 1, 13–16 (1989).Google Scholar
  7. 7.
    G. N. Kryzhanovskii, M. A. Atadzhanov, T. A. Voronina et al., Ibid.,Byull. Éksp. Biol., No. 2, 147–150.Google Scholar
  8. 8.
    G. N. Kryzhanovskii, M. A. Atadzhanov, and V. G. Kucheryanu, Ibid.,, No. 10, 404–407 (1989).Google Scholar
  9. 9.
    N. A. Losev, E. I. Tkachenko, and L. N. Shalkovskaya,Vest. AMN SSSR, No. 9, 23–30 (1985).Google Scholar
  10. 10.
    N. B. Man'kovskii and I. N. Karaban',Zh. Nevropatol. Psikhiatr., No. 9, 1404–1411 (1987).Google Scholar
  11. 11.
    V. A. Otellin and É. B. Arushanyan,The Nigrostriatal System [in Russian], Moscow (1989).Google Scholar
  12. 12.
    L. S. Petelin,The Pathogenesis, Clinical Picture, and Treatment of Parkinsonism [in Russian], Moscow (1978), pp. 143–146.Google Scholar
  13. 13.
    A. Barbeau,Handbook of Clinical Neurology, Vol. 49 New York (1986), pp. 87–152.Google Scholar
  14. 14.
    R. M. Beckstead,Brain Res.,335, No. 1, 153–159 (1985).PubMedGoogle Scholar
  15. 15.
    K. Chiba, A. Trevor, and W. Castagnoli,Biochem. Biophys. Res. Commun.,120, No. 2, 574–578 (1984).PubMedGoogle Scholar
  16. 16.
    W. R. G. Gibb,Br. J. Psychiatr., 153, No. 2, 254–255 (1988).Google Scholar
  17. 17.
    P. M. Groves,Brain Res., 5, No. 1, 109–132 (1983).Google Scholar
  18. 18.
    H. Halberg and D. Almgren,Acta Physiol. Scand.,129, No. 5, 407–413 (1987).Google Scholar
  19. 19.
    Z. Henderson and S. A. Greenfield,Neurosci. Lett.,68, No. 6, 3436–3458 (1987).Google Scholar
  20. 20.
    R. Martinez-Murillo, R. M. Villalba, and J. Rodrigo,Ibid.,,96, No. 1, 121–126 (1989).PubMedGoogle Scholar
  21. 21.
    R. T. Matthews and C. G. Chiou,Neuropharmacol.,17, 879–892 (1978).CrossRefGoogle Scholar
  22. 22.
    I. Mitchell, A. J. Cross, M. A. Sambrook, and A. R. Grossman,J. Neural Transmiss., Suppl. 15, 41–46 (1986).Google Scholar
  23. 23.
    L. M. Sayre, P. K. Arona, L. A. Iacofano, et al.,Eur. J. Pharmacol.,124, No. 2, 171–174 (1986).PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • G. N. Kryzhanovskii
    • 1
    • 2
    • 3
  • M. A. Atadzhanov
    • 1
    • 2
    • 3
  • T. A. Voronina
    • 1
    • 2
    • 3
  • L. N. Nerobkova
    • 1
    • 2
    • 3
  1. 1.Laboratory of the General Pathology of the Nervous System, Scientific Research Institute of General Pathology and Pathological PhysiologyRussian Academy of Medical SciencesRussia
  2. 2.the Central Scientific Research Laboratory of the Tashkent Institute of the Advanced Training of PhysiciansRussia
  3. 3.Laboratory of Psychopharmacology of the Scientific Research Institute of PharmacologyRussian Academy of Medical SciencesRussia

Personalised recommendations